Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives
- PMID: 18760864
- DOI: 10.1016/j.ejmech.2008.07.020
Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives
Abstract
Comparative quantitative structure-activity relationship (QSAR) studies have been carried out on tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepine (TIBO) derivatives as reverse transcriptase inhibitors (n=70) using topological, structural, physicochemical, electronic and spatial descriptors. The data set was divided into training and test sets using a cluster-based method. Linear models were developed using multiple regression (with stepwise regression, factor analysis and genetic function approximation (GFA) as variable selection tools) and partial least squares (PLS) and combination of factor analysis and partial least squares (FA-PLS). Genetic function approximation (spline) and artificial neural networks (ANN) were used for the development of non-linear models. Using topological and structural descriptors, the best equation was obtained from GFA (spline) based on internal validation (Q(2)=0.737), but the model with the best external validation characteristics was obtained with FA-PLS (R(pred)(2)=0.707). When structural, physicochemical, electronic and spatial descriptors were used, the best Q(2) (0.740) value was obtained from GFA (spline) whereas PLS provided the best R(pred)(2) (0.784) value. When all descriptors were used in combination, the best R(pred)(2) (0.760) value and the best Q(2) (0.800) value were obtained from ANN and GFA (spline), respectively. The majority of the models satisfied the criteria of external validation recommended by Golbraikh and Tropsha (2002) and the criteria of modified r(2) (r(m)(2)) values of the test set for external validation as suggested by Roy and Roy (2008). In order to further validate selected models, an external set of 10 TIBO derivatives, which fall within the applicability domain of the models and are not shared with the compounds of the present data set, was taken from a different source, and reverse transcriptase inhibitory activity of these compounds was predicted. Acceptable values of squared correlation coefficients between the observed and predicted values of the external set compounds were obtained from the selected models suggesting true predictive potential of the models.
Similar articles
-
MIA-QSAR coupled to principal component analysis-adaptive neuro-fuzzy inference systems (PCA-ANFIS) for the modeling of the anti-HIV reverse transcriptase activities of TIBO derivatives.Eur J Med Chem. 2010 Apr;45(4):1352-8. doi: 10.1016/j.ejmech.2009.12.028. Epub 2010 Jan 4. Eur J Med Chem. 2010. PMID: 20060625
-
Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.Eur J Med Chem. 2008 Jan;43(1):81-92. doi: 10.1016/j.ejmech.2007.02.021. Epub 2007 Mar 14. Eur J Med Chem. 2008. PMID: 17452064
-
A group center overlap based approach for "3D QSAR" studies on TIBO derivatives.J Comput Chem. 2009 Apr 30;30(6):922-33. doi: 10.1002/jcc.21114. J Comput Chem. 2009. PMID: 18785154
-
From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase.J Med Chem. 2005 Mar 24;48(6):1689-96. doi: 10.1021/jm040127p. J Med Chem. 2005. PMID: 15771411 Review. No abstract available.
-
Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors.ChemMedChem. 2007 Aug;2(8):1141-7. doi: 10.1002/cmdc.200700054. ChemMedChem. 2007. PMID: 17477343 Review. No abstract available.
Cited by
-
Current mathematical methods used in QSAR/QSPR studies.Int J Mol Sci. 2009 Apr 29;10(5):1978-1998. doi: 10.3390/ijms10051978. Int J Mol Sci. 2009. PMID: 19564933 Free PMC article. Review.
-
Prediction of inhibitory activity of epidermal growth factor receptor inhibitors using grid search-projection pursuit regression method.PLoS One. 2011;6(7):e22367. doi: 10.1371/journal.pone.0022367. Epub 2011 Jul 21. PLoS One. 2011. PMID: 21811593 Free PMC article.
-
In Silico SAR Studies of HIV-1 Inhibitors.Pharmaceuticals (Basel). 2018 Jul 13;11(3):69. doi: 10.3390/ph11030069. Pharmaceuticals (Basel). 2018. PMID: 30011783 Free PMC article.
-
Evaluation of the antioxidant properties of curcumin derivatives by genetic function algorithm.J Adv Res. 2018 Mar 28;12:47-54. doi: 10.1016/j.jare.2018.03.003. eCollection 2018 Jul. J Adv Res. 2018. PMID: 30050693 Free PMC article.
-
HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors.J Cheminform. 2018 Mar 9;10(1):12. doi: 10.1186/s13321-018-0266-y. J Cheminform. 2018. PMID: 29524011 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information